RxDoctor Payments Data

Javier Mendez Ruiz

Allergy & Immunology · Mayaguez, PRNPI 1205086410

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $827, 5.2 times the $159 reported in 2019.

$3,316in general payments, 2019–2025

Across 111 payments — averaging $29.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$778
  • Sanofi$438
  • AstraZeneca$380
  • GSK$277
  • PBG Puerto Rico LLC$242
  • Amgen$216
  • plus $986 from 11 others

What the payments were for

  • Food & beverage$3,26698%
  • Education$502%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,316 in reported general payments places this provider in the 55th percentile of 25 allergy & immunology providers in Puerto Rico.

See all allergy & immunology providers in Puerto Rico

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab192$732,305
RinvoqUpadacitinib27$173,034
XolairOmalizumab29$77,171
Dupixent PenDupilumab13$49,685
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$24,195
Breo ElliptaFluticasone/Vilanterol32$13,290
Wixela InhubFluticasone Propion/Salmeterol51$12,076
Epinephrine30$8,511
Spiriva RespimatTiotropium Bromide14$7,477
Triamcinolone Acetonide327$7,101
Betamethasone Valerate195$6,111
Ipratropium Bromide168$5,732
Clobetasol Propionate67$5,418
Metronidazole46$5,276
Fluticasone Propionate250$3,817

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$778$173,03427 claims
Genentech, Inc.Xolair$163$77,17129 claims
GSKTrelegy Ellipta, Breo Ellipta$277$37,48568 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 25 allergy & immunology providers in Puerto Rico.

Other allergy & immunology in Mayaguez

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →